World's Best Scientists 2026 revealed!
Michelle Rosenzwajg

Michelle Rosenzwajg

D-Index & Metrics

Immunology

D-Index
50
Citations
10355
World Ranking
4228
National Ranking
201

Michelle Rosenzwajg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michelle Rosenzwajg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 136 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michelle Rosenzwajg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michelle Rosenzwajg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michelle Rosenzwajg is affiliated with Sorbonne University in France. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Rheumatology, Oncology, Genetics, and Pulmonary and Respiratory Medicine.

The scientist's work covers multiple main topics, including:

  • Systemic Lupus Erythematosus Research
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Adolescent and Pediatric Healthcare
  • T-cell and B-cell Immunology
  • Vasculitis and related conditions
  • Tryptophan and brain disorders

Michelle Rosenzwajg has frequently published in venues such as:

  • Annals of the Rheumatic Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Autoimmunity
  • La Revue de Médecine Interne
  • Nature Medicine

Recent papers featuring their research include:

  • Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study, 2020, Microbiome
  • Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis, 2023, Cancer Discovery
  • Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities, 2020, Autoimmunity Reviews
  • Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial, 2022, Critical Care
  • Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study, 2020, Diabetologia

The scientist collaborates frequently with several researchers, including:

  • David Klatzmann
  • Nicolas Tchitchek
  • P. Cacoub
  • Roberta Lorenzon
  • David Saadoun

Best Publications

  • Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

    David Saadoun;Michelle Rosenzwajg;Florence Joly;Adrien Six

  • Differentiation of human dendritic cells from monocytes in vitro

    Françoise Chapuis;Michelle Rosenzwajg;Micael Yagello;Marianne Ekman

  • Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

    Agnès Hartemann;Gilbert Bensimon;Christine A Payan;Sophie Jacqueminet

  • Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice

    Antoine Monsel;Ying-gang Zhu;Stephane Gennai;Qi Hao

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

    nathalie chaput;Samy Louafi;armelle Bardier;frederic charlotte

  • Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

    Harry Sokol;Cecilia Landman;Philippe Seksik;Laurence Berard

  • Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

    Michelle Rosenzwajg;Guillaume Churlaud;Roberto Mallone;Adrien Six

  • Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis

    D. Saadoun;M. Garrido;C. Comarmond;A. C. Desbois

  • Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.

    Aixin Yu;Isaac Snowhite;Francesco Vendrame;Michelle Rosenzwajg;Michelle Rosenzwajg

  • Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease

    Guillaume Geri;Benjamin Terrier;Michelle Rosenzwajg;Bertrand Wechsler

  • Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

    Benjamin Terrier;Benjamin Terrier;Benjamin Terrier;Nicolas Derian;Nicolas Derian;Yoland Schoindre;Wahiba Chaara;Wahiba Chaara

  • Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy

    Guillaume Churlaud;Fabien Pitoiset;Fabien Pitoiset;Fadi Jebbawi;Roberta Lorenzon;Roberta Lorenzon

  • Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells

    Ludovic Tailleux;Olivier Neyrolles;Stéphanie Honoré-Bouakline;Emmanuelle Perret

  • Human Dendritic Cell Differentiation Pathway From CD34+ Hematopoietic Precursor Cells

    Michelle Rosenzwajg;Bruno Canque;Jean Claude Gluckman

  • MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations.

    M.-H. Stern;J. Soulier;M. Rosenzwajg;K. Nakahara

  • Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

    Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach

  • Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.

    Benjamin Terrier;Ivan Bièche;Thierry Maisonobe;Ingrid Laurendeau

  • Interleukin 21 Correlates with T Cell and B Cell Subset Alterations in Systemic Lupus Erythematosus

    Benjamin Terrier;Nathalie Costedoat-Chalumeau;Marlène Garrido;Guillaume Geri

  • B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab

    Michelle Rosenzwajg;Michelle Rosenzwajg;Eva Languille;Eva Languille;Hanna Debiec;Hanna Debiec;Joana Hygino

  • CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

    Sébastien Maury;François M. Lemoine;Yosr Hicheri;Michelle Rosenzwajg

Frequent Co-Authors

David Klatzmann
David Klatzmann Sorbonne University
David Saadoun
David Saadoun Université Paris Cité
Patrice Cacoub
Patrice Cacoub Sorbonne University
Lucile Musset
Lucile Musset Sorbonne University
Claude C.A. Bernard
Claude C.A. Bernard Monash University
Olivier Benveniste
Olivier Benveniste Sorbonne University
Nathalie Chaput
Nathalie Chaput Institut Gustave Roussy
Eric Vicaut
Eric Vicaut Université Paris Cité
Alberto Pugliese
Alberto Pugliese University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring online degree options in nursing and healthcare can broaden career opportunities. Many students start with an best online BSN programs for non nurses to transition into the healthcare field without prior experience. These programs are designed to provide foundational nursing knowledge quickly and efficiently.

Once foundational knowledge is gained, students often seek advanced credentials. Accelerated pathways such as accelerated NP programs online offer a faster route to becoming Nurse Practitioners, combining flexibility with rigorous training that complements immunology expertise.

For those looking for more accessible entry points, accelerated nursing programs near me provide options with streamlined admissions and intensive curricula, ideal for dedicated students eager to advance quickly.

Similarly, easy admission LPN programs can serve as practical stepping stones into healthcare careers, offering foundational skills needed for patient care and immunology-related roles in clinical settings.

Best Scientists Citing Michelle Rosenzwajg

Trending Scientists

Recently Published Articles